CREST-2 Trial: Carotid Artery Stenting for Asymptomatic Carotid Stenosis

crest 2 trial

CREST-2 Trials (2025)

Medical Management vs Revascularization for Asymptomatic Carotid Stenosis
Two parallel, observer-blinded randomized clinical trials (Stenting + CEA)


Objective:
To determine whether adding carotid revascularization (stenting or endarterectomy) to intensive medical management provides additional benefit over medical therapy alone in patients with high-grade asymptomatic carotid stenosis.


Inclusion Criteria (2–3 lines):

Adults ≥35 years with asymptomatic high-grade carotid stenosis ≥70% (confirmed by angiography, CTA, MRA, or Doppler criteria) and no ipsilateral stroke/TIA within 180 days, with good functional status (mRS 0–1) and suitable for stenting or endarterectomy.


Population:
Across 155 centers in 5 countries

  • Stenting trial: 1,245 patients
  • CEA trial: 1,240 patients
    All received ** intensive medical therapy**, with or without revascularization.

Follow-up: Up to 4 years


Primary Outcome:

Composite of peri-procedural stroke/death (0–44 days) + ipsilateral ischemic stroke up to 4 years


Results:

Stenting Trial

  • Medical therapy: 6.0% event rate
  • Stenting + medical therapy: 2.8%
  • P = 0.02 (absolute difference)Significant benefit
  • Peri-procedural (0–44 days): 0 strokes/deaths vs 8 events in stenting

Endarterectomy Trial

  • Medical therapy: 5.3%
  • CEA + medical therapy: 3.7%
  • P = 0.24 (not significant)
  • Peri-procedural strokes: 3 vs 9 with CEA

Interpretation:

  • Stenting + medical therapy reduced long-term stroke risk compared with medical therapy alone, despite peri-procedural risks.
  • Carotid endarterectomy did not show a statistically significant benefit over medical therapy alone.
  • Advancements in modern intensive medical therapy have narrowed the advantage of surgical/endovascular treatment for asymptomatic disease.

Conclusion:
For asymptomatic high-grade carotid stenosis, stenting (with optimized medical therapy) provided a statistically significant stroke-reduction benefit over intensive medical therapy alone, whereas endarterectomy did not. Optimal medical therapy remains central and may reduce the need for surgery in many patients.


Citation:
Brott TG, Howard G, Lal BK, et al. N Engl J Med. 2025; DOI: 10.1056/NEJMoa2508800

Comments are closed.